Abstract
The optimal thoracic radiation dose for patients with extensive stage small cell lung cancer (ES-SCLC) who respond to chemotherapy remains unclear. This study aims to determine whether high-dose thoracic radiotherapy has superior efficacy compared with standard-dose thoracic radiotherapy in ES-SCLC patients.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
